COM:ADVERUM
Adverum Biotechnologies
- Stock
Last Close
5.75
22/11 21:00
Market Cap
161.49M
Beta: -
Volume Today
440.65K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 645.50K - | 860K 33.23% | 778K 9.53% | 1.04M 33.61% | 1.60M 54.16% | 1.72M 7.27% | 2.90M 68.99% | 3.46M 18.98% | 2.10M 39.29% | 1.81M 13.63% | 2.08M 14.73% | |
average receivables | 4.50K - | 4K 11.11% | 224.50K 5,512.50% | 667.50K 197.33% | 443K 33.63% | 2.85M - | 2.85M 0% | |||||
book value per share | -0.01 - | 6.57 62,706.59% | 9.77 48.69% | 5.95 39.11% | 4.21 29.14% | 3.28 22.24% | 2.73 16.73% | 5.10 86.90% | 3.23 36.78% | 1.83 43.29% | 0.83 54.73% | |
capex per share | -0.00 - | -0.04 846.14% | -0.12 179.19% | -0.07 42.49% | -0.02 65.03% | -0.01 43.36% | -0.30 2,177.90% | -0.14 53.67% | -0.15 10.89% | -0.12 22.82% | -0.01 93.27% | |
capex to depreciation | -3.50 - | -5.82 66.31% | -3.68 36.70% | -1.50 59.16% | -0.48 67.78% | -0.46 4.63% | -12.24 2,546.82% | -2.85 76.72% | -3.26 14.30% | -1.81 44.40% | -0.14 92.09% | |
capex to operating cash flow | 0.04 - | 0.17 299.06% | 0.08 49.29% | 0.06 25.75% | 0.02 64.42% | 0.01 32.98% | 0.39 2,511.07% | 0.15 61.84% | 0.14 6.11% | 0.11 22.06% | 0.01 91.87% | |
capex to revenue | -0.19 - | -1.65 769.59% | -1.29 21.74% | -1.66 28.49% | -0.55 66.85% | -0.50 8.67% | -76.99 15,240.50% | -2.02 - | ||||
cash per share | 0.03 - | 7.01 25,705.06% | 11.48 63.85% | 6.13 46.60% | 4.36 28.82% | 3.34 23.41% | 2.59 22.48% | 5.05 94.85% | 3.11 38.32% | 1.87 39.93% | 0.96 48.80% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 6.08 - | 70.67 - | 222.26 214.50% | 277.84 - | ||||||||
debt to assets | 0.02 - | 0.02 32.33% | 0.03 90.86% | 0.04 19.06% | 0.14 - | 0.06 56.05% | 0.23 268.07% | 0.35 47.87% | 0.43 25.23% | |||
debt to equity | 0.02 - | 0.02 34.62% | 0.03 98.45% | 0.04 20.06% | 0.18 - | 0.07 61.64% | 0.33 360.74% | 0.59 80.63% | 0.90 52.79% | |||
dividend yield | ||||||||||||
earnings yield | -0.01 - | -0.02 127.87% | -0.19 832.33% | -1.08 461.39% | -0.37 66.05% | -0.38 2.24% | -0.09 76.75% | -0.13 45.79% | -0.84 562.52% | -2.68 218.27% | -1.54 42.50% | |
enterprise value | 580.93M - | 1.07B 84.07% | -12.90M 101.21% | -117.06M 807.07% | 82.29M 170.30% | 38.38M 53.36% | 704.81M 1,736.28% | 891.27M 26.46% | 241.35M 72.92% | 95.94M 60.25% | 75.94M 20.85% | |
enterprise value over ebitda | -164.85 - | -43.82 73.42% | 0.30 100.69% | -19.05 6,400.60% | -1.45 92.39% | -0.58 60.10% | -10.52 1,718.71% | -7.83 25.57% | -1.71 78.22% | -0.64 62.66% | -0.65 2.69% | |
ev to operating cash flow | -267.09 - | -189.33 29.12% | 0.37 100.19% | 3.05 735.48% | -1.81 159.38% | -0.71 60.74% | -14.33 1,915.32% | -11.24 21.58% | -2.24 80.09% | -0.89 60.35% | -0.84 5.88% | |
ev to sales | 1.21K - | 1.87K 54.46% | -5.56 100.30% | -80.45 1,345.70% | 44.51 155.32% | 23.81 46.50% | 2.82K 11,740.34% | 32.18 - | ||||
free cash flow per share | -0.11 - | -0.29 165.57% | -1.48 411.73% | -1.13 24.10% | -1.06 5.46% | -0.89 16.09% | -1.07 19.60% | -1.07 0.28% | -1.25 17.17% | -1.21 3.67% | -0.91 24.71% | |
free cash flow yield | -0.00 - | -0.01 37.65% | -0.16 2,802.66% | -0.39 149.16% | -0.30 21.67% | -0.28 6.77% | -0.09 67.30% | -0.10 6.57% | -0.71 621.67% | -2.08 192.31% | -1.21 41.99% | |
graham net net | -0.04 - | 6.46 18,408.04% | 11.04 70.87% | 5.62 49.05% | 3.95 29.71% | 3.14 20.56% | 1.84 41.25% | 4.48 142.86% | 1.90 57.67% | 0.59 68.80% | 0.07 88.29% | |
graham number | 0.24 - | 12.85 5,146.27% | 20.08 56.33% | 20.49 2.05% | 11.04 46.11% | 9.34 15.41% | 7.86 15.86% | 12.59 60.13% | 10.38 17.53% | 8.00 22.88% | 4.65 41.88% | |
income quality | 0.41 - | 0.22 46.07% | 0.74 234.95% | 0.34 54.71% | 0.81 139.84% | 0.74 8.15% | 0.76 2.62% | 0.67 11.50% | 0.74 9.80% | 0.70 5.59% | 0.78 10.92% | |
intangibles to total assets | 0 - | 0 | 0 | 0.02 Infinity% | 0.02 16.18% | 0 100% | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -47.32 - | -1.36K 2,765.19% | 58.79 - | |||||||||
interest debt per share | 0.00 - | 0.16 4,533.94% | 0.16 3.27% | 0.19 20.84% | 0.16 14.93% | 0.50 - | 0.36 28.31% | 1.05 191.29% | 1.05 0.13% | 0.74 29.06% | ||
inventory turnover | ||||||||||||
invested capital | 0.02 - | 0.02 34.62% | 0.03 98.45% | 0.04 20.06% | 0.18 - | 0.07 61.64% | 0.33 360.74% | 0.59 80.63% | 0.90 52.79% | |||
market cap | 581.50M - | 1.23B 111.30% | 246.18M 79.96% | 105.11M 57.30% | 152.81M 45.38% | 193.33M 26.51% | 738.46M 281.96% | 922.98M 24.99% | 172.55M 81.31% | 57.57M 66.64% | 75.90M 31.85% | |
net current asset value | -481K - | 147.85M 30,839.09% | 249.26M 68.59% | 206.29M 17.24% | 175.86M 14.75% | 196.43M 11.69% | 128.10M 34.78% | 386.22M 201.50% | 193.60M 49.87% | 63.74M 67.08% | 13.23M 79.24% | |
net debt to ebitda | 0.16 - | 6.53 3,981.60% | 6.07 7.07% | -36.16 695.65% | 1.24 103.44% | 2.34 87.99% | 0.50 78.49% | 0.28 44.53% | -0.49 274.47% | -0.25 47.61% | -0.00 99.88% | |
net income per share | -0.25 - | -1.12 339.62% | -1.84 64.37% | -3.14 71.01% | -1.29 59.02% | -1.18 7.98% | -1.01 14.99% | -1.38 37.18% | -1.48 7.57% | -1.56 4.88% | -1.16 25.37% | |
operating cash flow per share | -0.10 - | -0.25 137.09% | -1.37 450.55% | -1.06 22.54% | -1.04 1.72% | -0.88 15.48% | -0.77 12.76% | -0.93 21.40% | -1.10 18.11% | -1.09 0.98% | -0.90 17.21% | |
payables turnover | ||||||||||||
receivables turnover | 60 - | 5.16 - | 1.64 68.20% | 1.31 - | ||||||||
research and ddevelopement to revenue | 4.48 - | 29.68 562.28% | 10.98 63.00% | 21.77 98.24% | 21.55 1.01% | 31.10 44.34% | 161.68 419.86% | 11.89 - | ||||
return on tangible assets | -4.86 - | -0.16 96.77% | -0.18 14.42% | -0.50 175.97% | -0.29 42.45% | -0.34 19.30% | -0.29 14.89% | -0.24 15.90% | -0.33 35.92% | -0.50 51.41% | -0.68 35.14% | |
revenue per share | 0.02 - | 0.03 8.80% | 0.09 256.74% | 0.04 55.24% | 0.04 5.50% | 0.03 37.98% | 0.00 85.15% | 0.08 - | ||||
roe | 24.20 - | -0.17 100.70% | -0.19 10.54% | -0.53 180.83% | -0.31 42.17% | -0.36 18.33% | -0.37 2.09% | -0.27 26.60% | -0.46 70.14% | -0.85 84.96% | -1.40 64.88% | |
roic | 15.77 - | -0.16 101.00% | -0.19 22.07% | -0.51 166.32% | -0.31 40.16% | -0.38 23.91% | -0.29 24.98% | -0.24 16.09% | -0.28 16.50% | -0.40 42.18% | -0.50 26.07% | |
sales general and administrative to revenue | 3.71 - | 13.98 276.42% | 9.53 31.82% | 16.74 75.59% | 11.28 32.61% | 15.24 35.07% | 113.50 644.99% | 8.59 - | ||||
shareholders equity per share | -0.01 - | 6.57 62,706.59% | 9.77 48.69% | 5.95 39.11% | 4.21 29.14% | 3.28 22.24% | 2.73 16.73% | 5.10 86.90% | 3.23 36.78% | 1.83 43.29% | 0.83 54.73% | |
stock based compensation to revenue | 1.07 - | 14.98 1,295.94% | 4.96 66.88% | 7.85 58.15% | 4.72 39.87% | 8.33 76.62% | 39.60 375.20% | 3.36 - | ||||
tangible asset value | -218K - | 149.48M 68,670.18% | 252.59M 68.98% | 210.60M 16.62% | 179.03M 14.99% | 201.17M 12.37% | 174.96M 13.03% | 434.35M 148.26% | 316.19M 27.20% | 181.52M 42.59% | 83.47M 54.02% | |
tangible book value per share | -0.01 - | 6.57 62,706.59% | 9.77 48.69% | 5.81 40.52% | 4.10 29.43% | 3.28 20.06% | 2.73 16.73% | 5.10 86.90% | 3.23 36.78% | 1.83 43.29% | 0.83 54.73% | |
working capital | -340K - | 154.81M 45,631.47% | 254.42M 64.35% | 215.38M 15.34% | 183.07M 15.00% | 198.03M 8.18% | 156.46M 20.99% | 413.57M 164.32% | 295.82M 28.47% | 158.35M 46.47% | 77.86M 50.83% |
All numbers in (except ratios and percentages)